Riboswitch Distribution in the Human Gut Microbiome Reveals Common Metabolite Pathways
The Journal of Physical Chemistry B · 09.05.2024 · 128 (18) · 4336-4343
DOI: 10.1021/acs.jpcb.4c00267 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, online erschienen am 24.04.2024. Verfasst von Giulio Quarta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYU Grossman School of Medicine, 450 East 29th St., Room 341, New York, New York 10016, United States. Hauptthemen laut MEDLINE: Riboswitch, Gastrointestinal Microbiome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Riboswitches are widely distributed, conserved RNAs which regulate metabolite levels in bacterial cells through direct, noncovalent binding of their cognate metabolite. Various riboswitch families are highly enriched in gut bacteria, suggestive of a symbiotic relationship between the host and bacteria. Previous studies of the distribution of riboswitches have examined bacterial taxa broadly. Thus, the distribution of riboswitches associated with bacteria inhabiting the intestines of healthy individuals is not well understood. To address these questions, we survey the gut microbiome for riboswitches by including an international database of prokaryotic genomes from the gut samples. Using Infernal, a program that uses RNA-specific sequence and structural features, we survey this data set using existing riboswitch models. We identify 22 classes of riboswitches with vitamin cofactors making up the majority of riboswitch-associated pathways. Our finding is reproducible in other representative databases from the oral as well as the marine microbiomes, underscoring the importance of thiamine pyrophosphate, cobalamin, and flavin mononucleotide in gene regulation. Interestingly, riboswitches do not vary significantly across microbiome representatives from around the world despite major taxonomic differences; this suggests an underlying conservation. Further studies elucidating the role of bacterial riboswitches in the host metabolome are needed to illuminate the consequences of our finding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, NYU Grossman School of Medicine, 450 East 29th St., Room 341, New York, New York 10016, United States.
- Department of Chemistry, New York University, 100 Washington Square East, Silver Building, New York, New York 10003, United States.
- Courant Institute of Mathematical Sciences, New York University, 251 Mercer Street, New York, New York 10012, United States.
- New York University-East China Normal University Center for Computational Chemistry, New York University Shanghai, Shanghai 200122, China.
- Simons Center for Computational Physical Chemistry, New York University, 24 Waverly Place, Silver Building, New York, New York 10003, United States.
ORCID-Profile: Giulio Quarta, Tamar Schlick
Förderung
- NCATS NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- National Science Foundation
- U.S. Department of Health and Human Services
- Division of Microbiology and Infectious Diseases
- NYU Grossman School of Medicine
Zitieren
APA
Quarta, G., & Schlick, T. (2024). Riboswitch Distribution in the Human Gut Microbiome Reveals Common Metabolite Pathways. The Journal of Physical Chemistry B, 128(18), 4336-4343. https://doi.org/10.1021/acs.jpcb.4c00267
Vancouver
Quarta G, Schlick T. Riboswitch Distribution in the Human Gut Microbiome Reveals Common Metabolite Pathways. The Journal of Physical Chemistry B. 2024;128(18):4336-4343. doi:10.1021/acs.jpcb.4c00267
BibTeX
@article{Quarta2024,
author = {Quarta, Giulio and Schlick, Tamar},
title = {Riboswitch Distribution in the Human Gut Microbiome Reveals Common Metabolite Pathways},
journal = {The Journal of Physical Chemistry B},
year = {2024},
volume = {128},
number = {18},
pages = {4336--4343},
doi = {10.1021/acs.jpcb.4c00267}
}
EUVIMED